Stem Cells in the Treatment of Renal Allograft Diseases

O. S. Nikonenko, I. Rusanov, T. N. Nykonenko, S. Vildanov
{"title":"Stem Cells in the Treatment of Renal Allograft Diseases","authors":"O. S. Nikonenko, I. Rusanov, T. N. Nykonenko, S. Vildanov","doi":"10.30702/transpaorg/10_21.2710/0278-83/576.3/4","DOIUrl":null,"url":null,"abstract":"In recent years, there has been growing interest in the use of stem cells as a therapeutic agent for the restoration of the damaged tissues and organs. \nWe present a clinical case. Male, 39 y.o. Diagnosis: Glomerulonephritis. On 10/09/2012, he underwent heterotopic renal allotransplantation from a live relative donor. On 09/23/2020, he was admitted to the hospital due to renal allograft pyelonephritis. On 10/28/2020, a cell based donor umbilical cord blood product was infused. Cell therapy enabled to minimize the consequences of the graft damage, to preserve the graft function and satisfactory condition of the recipient.","PeriodicalId":116695,"journal":{"name":"Transplantation and artificial organs","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation and artificial organs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30702/transpaorg/10_21.2710/0278-83/576.3/4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, there has been growing interest in the use of stem cells as a therapeutic agent for the restoration of the damaged tissues and organs. We present a clinical case. Male, 39 y.o. Diagnosis: Glomerulonephritis. On 10/09/2012, he underwent heterotopic renal allotransplantation from a live relative donor. On 09/23/2020, he was admitted to the hospital due to renal allograft pyelonephritis. On 10/28/2020, a cell based donor umbilical cord blood product was infused. Cell therapy enabled to minimize the consequences of the graft damage, to preserve the graft function and satisfactory condition of the recipient.
干细胞治疗同种异体肾移植疾病
近年来,人们对利用干细胞作为一种治疗药物来修复受损的组织和器官越来越感兴趣。我们报告一个临床病例。男,39岁。诊断:肾小球肾炎。2012年9月10日,他接受了来自活体亲属供体的异位肾移植。2020年9月23日因肾移植肾盂肾炎住院。2020年10月28日,输注基于细胞的供体脐带血制品。细胞治疗能够最大限度地减少移植物损伤的后果,保持移植物的功能和受体的满意状态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信